Evaluating the efficacy of inhaled amikacin as an adjunct to intravenous combination therapy (ceftazidime and amikacin) in pediatric cystic fibrosis pulmonary exacerbation
Background:Pseudomonas aeruginosa is the most common microorganism found in the sputum culture of Cystic fibrosis (CF) patients causing the pulmonary destruction. Aminoglycosides have a low diffuse rate from lipid membranes, and respiratory system secretions. Regarding the burden of pulmonary exacer...
Saved in:
Main Authors: | Amin Rakhshan (Author), Nazanin Farahbakhsh (Author), Ghamartaj Khanbabaee (Author), Seyed Ahmad Tabatabaii (Author), Saeed Sadr (Author), Maryam Hassanzad (Author), Mohammad Sistanizad (Author), Farzaneh Dastan (Author), Mahmoud Hajipour (Author), Amir Reza Bahadori (Author), Bahador Mirrahimi (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reagent-free determination of amikacin content in amikacin sulfate injections by FTIR derivative spectroscopy in a continuous flow system
by: José F. Ovalles, et al.
Published: (2014) -
Initial In Vivo Evaluation of a Novel Amikacin-Deoxycholate Hydrophobic Salt Delivers New Insights on Amikacin Partition in Blood and Tissues
by: Styliani Xiroudaki, et al.
Published: (2021) -
The Direction of the Antibacterial Effect of Rutin Hydrate and Amikacin
by: Maria Miklasińska-Majdanik, et al.
Published: (2023) -
Carvacrol attenuates amikacin-induced nephrotoxicity in the rats
by: Cemil Çolak, et al.
Published: (2024) -
The Use of Amikacin Liposome Inhalation Suspension (Arikayce) in the Treatment of Refractory Nontuberculous Mycobacterial Lung Disease in Adults
by: Khan O, et al.
Published: (2020)